PAMA Delay Proposed Until 2027 Under a New Federal Spending Bill
However, attorney Danielle Sloan urges labs to be proactive about potential PAMA reporting requirements on Jan. 31 if the bill doesn’t pass quickly
However, attorney Danielle Sloan urges labs to be proactive about potential PAMA reporting requirements on Jan. 31 if the bill doesn’t pass quickly
How clinical laboratories should prepare for the next wave of oversight in the new year
However, a proposed bill called the RESULTS Act is racing to thwart the cuts to lab test reimbursement rates
Government reform and payer streamlining may reduce the burden on healthcare providers, but laboratories should remain vigilant
Two revenue cycle management experts explain opportunities that clinical laboratories have with artificial intelligence
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
The free online tool can set a foundation for renewed reimbursement strategies and contract negotiations with insurance carriers
Sara Pirzadeh-Miller offers advice on overcoming the reimbursement barriers genetic counselors face in the clinical lab and beyond
The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025
Understanding the 2024 CLFS update—and the changes that are still to come.
An overview of likely lab audit targets for the coming year, and how laboratories can ensure they’re prepared.